Elite Pharmaceuticals, Inc. Business Combination, Consideration Transferred
Elite Pharmaceuticals, Inc. (ELTP) reported Business Combination, Consideration Transferred of $10.00 million for the 12-month period ending 2016-03-31, per its 10-K filed 2016-06-15.
Discontinued › Notes
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2016-06-15
- Elite Pharmaceuticals, Inc. business combination, consideration transferred for the quarter ending 2014-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. business combination, consideration transferred for fiscal 2016 was $10.00M, a 0.00% change from fiscal 2015.
- Elite Pharmaceuticals, Inc. business combination, consideration transferred for fiscal 2015 was $10.00M, a 0.00% change from fiscal 2014.
- Elite Pharmaceuticals, Inc. business combination, consideration transferred for fiscal 2014 was $10.00M.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month |
|---|---|---|---|
| 2016-03-31 | $10.00M 10-K · filed 2016-06-15 | ||
| 2015-03-31 | $10.00M 10-K · filed 2015-06-15 | ||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | $10.00M 10-K · filed 2014-06-30 | |
| 2013-12-31 | $10.00M 10-Q · filed 2014-02-14 |